Sherlock Biosciences

Sherlock Biosciences is an engineering biology company offering unparalleled breadth and versatility for diagnostic solutions. It leverages engineering biology tools, including CRISPR and Synthetic Biology, to create molecular diagnostics that can rapidly deliver accurate results for a vast range of needs in virtually any setting. They combine the diagnostic power of SHERLOCK with that of a second core platform technology, Internal Splint-Pairing Expression Cassette Translation Reaction, or INSPECTRTM, to create diagnostic tools that are simple and easy to use in virtually any setting, and at the same time provide accurate, rapid and affordable results.

SheSherlock Biosciences was founded in 2019 and is headquartered in Cambridge, Massachusetts, United States.

Sherlock Biosciences headquartered in United States, North America, operates in the Biotechnology, Life Science, Health Care, Health Diagnostics sector. The company focuses on Biotechnology and has secured $13.2B in funding across 96 round(s). With a team of 51-100 employees, Sherlock Biosciences is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Sherlock Biosciences, raised $2.0M. Discover more about their projects, partnerships, and impact on our platform.